Apotex Research Private Limited

Apotex Research Private Limited - pharma in Jigani Hobli, Karnataka, India. FY 2026 financials & compliance.
CIN U73100KA2003PTC032103 Incorporated 16 June 2003 ROC Bangalore HQ Jigani Hobli, Karnataka, India
Active Private Limited Company pharma
Revenue · FY 2025
₹727.34 Cr
▲ 22% YoY
Net profit · FY 2025
₹76.62 Cr
Net margin 10.5%
EBITDA · FY 2025
₹148.77 Cr
EBITDA margin 20.5%
Authorised capital
₹460 Cr
Registered with MCA
Paid-up capital
₹291.86 Cr
Issued & subscribed
Open charges
₹483.8 Cr
Secured borrowings
Company age
23 yrs
Est. 2003
Employees · EPFO
1,367
Provident fund records

About Apotex Research Private Limited

Data last updated:

Apotex Research Private Limited is a private limited company based in Jigani Hobli, Karnataka, India, a subsidiary of Apotex Pharmaceuticals Holdings Inc.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 June 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2003PTC032103. Its GSTIN is 29AAECA2791B1ZU (Karnataka). The company holds 3 GST registrations, all of them active.

The company has an authorised share capital of ₹460 Cr and a paid-up capital of ₹291.86 Cr. It is led by directors including Brian George Mcclelland and Goutam Vilas Pujari.

Its last annual general meeting (AGM) was held on 24 September 2024, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Site No.1 Bommasandra Industrial Area 1V Th Phase Jigani Link Road, Jigani Hobli, Karnataka, India – 562158.

As per the financials filed for FY 2025, the company reported a revenue of ₹727.34 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹76.62 Cr (net margin 10.5%) and EBITDA of ₹148.77 Cr (EBITDA margin 20.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 931% over five years.

The company has about 1,367 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Apotex Pharmachem India and Apotex. As per MCA filings, the company has open charges of ₹483.8 Cr on record. Court records list 19 cases involving the company, including 10 filed by the company and 9 filed against it; 2 cases are pending. The company has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹272.33 Cr; the latest was in March 2025. The company has 12 MSME Form 1 returns on record between 2016 and 2024, listing 120 overdue payments to 50 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apotex.com.

Company details

CIN U73100KA2003PTC032103
Registration Number 032103
Incorporation Date 16 June 2003
ROC Bangalore
Listing Status Unlisted
Company Status Active
Parent Company Apotex Pharmaceuticals Holdings Inc.
Compliance Status Active Compliant

Contact details

Apotex Research Private Limited's registered office is in Jigani Hobli, Karnataka. Its website is apotex.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    Site No.1 Bommasandra Industrial Area 1V Th Phase Jigani Link Road, Jigani Hobli, Karnataka, India – 562158
  • Industry
    Pharma, Drug Formulation & Development, Pharma Contract R&D

To see the full contact details of Apotex Research Private Limited, buy the company report.

Comprehensive company report
Apotex Research Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Apotex Research operates two associated brands: Apotex Pharmachem India and Apotex. Each brand links to its own profile.

BrandDescriptionWebsite
Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care.apotex.co.in
Generic pharmaceutical formulations are manufactured and exported by Apotex globally.apotex.com

Business activity

The main business activities of Apotex Research are manufacturing and professional, scientific and technical. In detail, this covers manufacture of chemicals and chemical products and scientific research and development. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing20Manufacture of chemicals and chemical products
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Apotex Research Private Limited, buy the company report.

Financials of Apotex Research Private Limited

FY 2025 filings available

Apotex Research Private Limited reported revenue of ₹727.34 Cr (up 22% YoY) for FY 2025.

Revenue · FY 2025
₹727.34 Cr ▲ 22%
Net profit · FY 2025
₹76.62 Cr margin 10.5%
EBITDA · FY 2025
₹148.77 Cr margin 20.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 10%
5 years · compounded
▲ 931%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 9%
5 years · compounded
▲ 915%

Revenue has grown at a compounded annual rate (CAGR) of 931% over five years, including 22% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹727.34 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹148.77 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹76.62 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin20.5%
Net Profit Margin10.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Apotex Research Private Limited, buy the company report.

Board of directors of Apotex Research Private Limited

Apotex Research has 4 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Brian George McclellandDirector15 Sep 20233 Years 2 MonthsCurrent
Rajesh SalwanAdditional Director18 Mar 20251 Years 8 MonthsCurrent
Goutam Vilas PujariDirector01 Dec 20187 Years 11 MonthsCurrent
Uta Kellermann RentonAdditional Director18 Mar 20251 Years 8 MonthsCurrent

Auditor

Apotex Research Private Limited is audited by Haribhakti & Co. LLP for the financial year 2025.

Auditor firmFinancial yearFirm registration number
Haribhakti & Co. LLPFY 2025103523W/W100048

Shareholding

The shareholding of Apotex Research Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2025FY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Apotex Research Private Limited, buy the company report.

Charges & borrowings

Open charges
₹483.8 Cr
Satisfied charges
None
Breakdown by lending institutions
Apotex Pharmaceutical Holdings Inc₹250.00 Cr
The Hongkong and Shanghai Banking Corporation Limited₹198.80 Cr
Others₹35.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Sep 2023100801520Others₹30 CrOpen
09 Jun 2017100107924Others₹5 CrOpen
24 Mar 2016100017935The Hongkong and Shanghai Banking Corporation Limited₹80 LakhOpen
17 Oct 201210381903The Hongkong and Shanghai Banking Corporation Limited₹198 CrOpen
31 Mar 200610004034Apotex Pharmaceutical Holdings Inc₹250 CrOpen

To see the full charge records of Apotex Research Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Apotex Research Private Limited has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹272.33 Cr; the latest was in March 2025.

Total deals
4
Funding rounds
3
Secondary share transfer
1
Disclosed funding
₹272.33 Cr

Deals on record (4 of 4)

WhenDealAmountParties
Mar 2025Secondary share transferUndisclosedBuyer: Apotex Inc, Ontario Inc
Seller: Apotex Pharmaceutical Holdings Inc, Apotex Pharmachem Inc
Apr 2011Funding round₹207.64 CrInvestors: Apotex Pharmaceutical Holdings Inc
Mar 2009Funding round₹36.24 CrInvestors: Apotex Pharmaceutical Holdings Inc
Jul 2007Funding round₹28.45 CrInvestors: Apotex Pharmaceutical Holdings Inc

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Apotex Research Private Limited has 12 MSME Form 1 returns on record between 2016 and 2024, listing 120 overdue payments to 50 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 50)

SupplierAmount dueDue sinceReported on
Mokshy Surgical
an individual supplier
an individual supplier
Esskay Compuservices Private Limited
Asian Filtration Technology

To see the full MSME payment records of Apotex Research Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Apotex Research Private Limited has a workforce of 1,367 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
1,367
Active EPFO establishments
1
Employee growth
8.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-271,367
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Apotex Research Private Limited, buy the company report.

GST

Apotex Research has 3 GST registrations: 3 active.

Total GSTINs
3
Active
3
GSTINStateStatusRegistered on
29AAECA2791B1ZUKarnatakaActive01 Jul 2017
29AAECA2791B2ZTKarnatakaActive21 Mar 2025
27AAECA2791B1ZYMaharashtraActive09 Aug 2017

To see the full GST registrations and return filing status of Apotex Research Private Limited, buy the company report.

Recent activity

Apotex Research Private Limited has 17 board changes on record since 2015: 5 appointments and 12 cessations. The latest: Rajesh Salwan was appointed as Additional Director on 18 Mar 2025.

Filing
Apotex Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Rajesh Salwan was appointed as Additional Director.
Appointed
Uta Kellermann Renton was appointed as Additional Director.
AGM
Apotex Research Private Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records.
Ceased
Kajal Palan ceased to be Additional Director.
Appointed
Kajal Palan was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 100801520 was registered on 30 Sep 2023.
Ceased
Brian George Mcclelland ceased to be Additional Director.
Appointed
Brian George Mcclelland was appointed as Director.
Ceased
Goutam Vilas Pujari ceased to be Additional Director.
Ceased
Yoganjaneya Reddy Panem ceased to be Additional Director.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 0.80 Cr registered on 24 Mar 2016 with Charge ID 100017935 was modified on 30 Jul 2019.

16 earlier events are in the company report.

Frequently asked questions

Apotex Research is an active private limited company based in Jigani Hobli, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 June 2003 (23+ years old) and is registered under CIN U73100KA2003PTC032103.

Apotex Research has 4 current directors:

The latest financial statements of Apotex Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Apotex Research is 29AAECA2791B1ZU, registered in Karnataka. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 29AAECA2791B2ZT (Karnataka), 27AAECA2791B1ZY (Maharashtra).

The CIN (Corporate Identification Number) of Apotex Research is U73100KA2003PTC032103. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Apotex Research has 19 court cases on record: 10 filed by the company and 9 filed against it. 2 are pending. Most are in the high courts.

Apotex Research was incorporated on 16 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Bangalore.

Apotex Research has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹272.33 Cr; the latest was in March 2025.

Rajesh Salwan was appointed as Additional Director on 18 Mar 2025. Uta Kellermann Renton was appointed as Additional Director on 18 Mar 2025. Kajal Palan ceased to be Additional Director on 23 Sep 2024. Apotex Research has 17 board changes on record in total.

Apotex Research has 12 MSME Form 1 returns on record between 2016 and 2024, listing 120 overdue payments to 50 micro and small suppliers. The latest return was filed on 23 Apr 2024.

Apotex Research can be reached through the website apotex.com. Its registered office is in Jigani Hobli, Karnataka, India.